We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Emerging Focused Ultrasound Technology Expected to help Revolutionize Neurological Care

By MedImaging International staff writers
Posted on 10 May 2015
Transcranial focused ultrasound, guided by Magnetic Resonance Imaging (MRI), and focused ultrasound used with microbubbles, have been named one of 12 emerging technologies that have the potential to revolutionize neurological and psychiatric care over the next ten years.

The selection was made by more than 50 neuroscience experts, and an academic panel at the World Medical Information Forum (Boston, MA, USA) that took place at the end of April 2015.

The forum was organized by Partners Healthcare (Boston, MA, USA), one of the USA’s leading biomedical research organizations. Focused ultrasound was selected because it can be used to precisely target tissue deep in the body without surgery or harmful radiation, and causes potentially less pain, has fewer risks, and enables a faster recovery.

According to Partners Healthcare, “Focused ultrasound has the ability to revolutionize the treatment of conditions such as brain cancer and Alzheimer’s through its potential for greater precision and faster patient recovery.”

Related Links:

Partners Healthcare
World Medical Information Forum 



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Mobile Digital C-arm X-Ray System
HHMC-200D
New
X-Ray Detector
FDR-D-EVO III
Computed Tomography (CT) Scanner
Aquilion Serve SP

Latest MRI News

World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients